Skip links

Medical

Cancer Research

Xylonix and Genecast Join Forces to Transform Cancer Metastasis Research

Xylonix, a fast-growing Singapore-based pharmaceutical company specializing in innovative oncology and immunology products, is proud to announce a strategic partnership with Genecast, a pioneering cancer diagnostics company from Korea. This collaboration aims to advance the field of early precision cancer diagnostics and cancer metastasis research, leveraging

Delveinsight

Fanconi Anemia Market Expected to Experience Major Growth by 2034, According to DelveInsight | Novartis, Foresee Pharma, Rocket Pharma, Jasper Therapeutics

The Key Fanconi Anemia Companies in the market include – Rocket Pharma, Foresee Pharmaceuticals, Jasper Therapeutics, Novartis, and others. DelveInsight’s “Fanconi Anemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Fanconi Anemia, historical and forecasted epidemiology as well as the Fanconi Anemia

Gravity Diagnostics Announces New Director of Compliance

Covington, Kentucky, Dec. 21, 2022 – Gravity Diagnostics, a CAP-accredited, CLIA-certified laboratory licensed in all 50 states, has officially welcomed Erica Adams as their Director of Compliance.  Ms. Adams will oversee the compliance program across the company, deciphering current and proposed legislation, and implementing structures